» Authors » Julio Ramirez

Julio Ramirez

Explore the profile of Julio Ramirez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 167
Citations 2081
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Coyle C, Watson L, Whately-Smith C, Brooke M, Kiltz U, Lubrano E, et al.
Rheumatology (Oxford) . 2024 Jan; 64(1):242-251. PMID: 38191998
Objectives: The AsseSSing Impact in pSoriatic Treatment (ASSIST) study investigated prescribing in routine PsA care and whether the patient-reported outcome-PsA Impact of Disease questionnaire (PsAID-12)-impacted treatment. This study also assessed...
12.
Navarro-Compan V, Puig L, Vidal S, Ramirez J, Llamas-Velasco M, Fernandez-Carballido C, et al.
Front Immunol . 2023 Dec; 14:1332177. PMID: 38077344
[This corrects the article DOI: 10.3389/fimmu.2023.1191782.].
13.
Ramirez J, Furmanek S, Chandler T, Wiemken T, Peyrani P, Arnold F, et al.
Microorganisms . 2023 Nov; 11(11). PMID: 38004825
remains a primary pathogen in hospitalized patients with community-acquired pneumonia (CAP). The objective of this study was to define the epidemiology of pneumococcal pneumonia in Louisville, Kentucky, and to estimate...
14.
Valero-Martinez C, Font Urgelles J, Salles M, Joven-Ibanez B, de Juanes A, Ramirez J, et al.
Front Immunol . 2023 Nov; 14:1283251. PMID: 37936691
Dual targeted therapy (DTT) has emerged as a promising approach in patients with refractory spondyloarthritis (SpA) or psoriatic arthritis (PsA) and extra-musculoskeletal manifestations of both diseases, but its effectiveness/safety ratio...
15.
Navarro-Compan V, Puig L, Vidal S, Ramirez J, Llamas-Velasco M, Fernandez-Carballido C, et al.
Front Immunol . 2023 Aug; 14:1191782. PMID: 37600764
Interleukin-17 family (IL-17s) comprises six structurally related members (IL-17A to IL-17F); sequence homology is highest between IL-17A and IL-17F, displaying certain overlapping functions. In general, IL-17A and IL-17F play important...
16.
Frade-Sosa B, Chacur C, Auge J, Ponce A, Sarmiento-Monroy J, Azuaga A, et al.
Cancers (Basel) . 2023 Jun; 15(11). PMID: 37296947
Background: this is an exploratory study to evaluate calprotectin serum levels in patients with rheumatic immune-related adverse events (irAEs) induced by immune checkpoint inhibitor (ICI) treatment. Methods: this is a...
17.
Bartlett A, Mendes E, Dahmash L, Palmeirim M, de Almeida M, Peliganga L, et al.
PLoS Negl Trop Dis . 2023 May; 17(5):e0010849. PMID: 37196040
Background: A school preventive chemotherapy (PC) program for soil-transmitted helminths (STHs) and schistosomiasis has operated in Huambo, Uige and Zaire provinces, Angola, since 2013 and 2014, respectively; complemented by a...
18.
Ramirez J, Carrico R, Wilde A, Junkins A, Furmanek S, Chandler T, et al.
Infect Dis Ther . 2023 May; 12(6):1593-1603. PMID: 37148463
Introduction: Nearly all existing respiratory syncytial virus (RSV) incidence estimates are based on real-time polymerase chain reaction (RT-PCR) testing of nasal or nasopharyngeal (NP) swabs. Adding testing of additional specimen...
19.
Richette P, Vis M, Ohrndorf S, Tillett W, Ramirez J, Neuhold M, et al.
RMD Open . 2023 Mar; 9(1). PMID: 37001920
Objectives: Psoriatic arthritis (PsA) phenotypes are typically defined by their clinical components, which may not reflect patients' overlapping symptoms. This post hoc analysis aimed to identify hypothesis-free PsA phenotype clusters...
20.
Sandhu H, Lambert J, Steckler Z, Park L, Stromberg A, Ramirez J, et al.
PLoS One . 2023 Mar; 18(3):e0282961. PMID: 37000808
The COVID-19 pandemic remains the pre-eminent global health problem, and yet after more than three years there is still no prophylactic agent against the disease aside from vaccines. The objective...